Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10363249 | Fatty acid synthase inhibitor for use in the treatment of drug resistant cancer | — | 2019-07-30 |
| 10226449 | Heterocyclic modulators of lipid synthesis and combinations thereof | Johan D. Oslob, Robert McDowell, Russell Johnson, Hanbiao Yang, Marc Evanchik +6 more | 2019-03-12 |
| 10189822 | Heterocyclic modulators of lipid synthesis | Johan D. Oslob, Robert McDowell, Russell Johnson, Hanbiao Yang, Marc Evanchik +6 more | 2019-01-29 |
| 9994550 | Heterocyclic modulators of lipid synthesis for use against cancer and viral infections | Allan S. Wagman, Russell Johnson, Cristiana A. Zaharia, Haiying Cai, Lily W. Hu +3 more | 2018-06-12 |
| 8771942 | SCDs as modifiers of the p53 pathway and methods of use | Marcia Belvin, Helen Francis-Lang, Lori Friedman, Gregory D. Plowman | 2014-07-08 |
| 8758994 | CDK9 as modifier of the IGF pathway and methods of use | Mark E. Maxwell, Michael OLLMANN, Lynn Margaret Bjerke | 2014-06-24 |
| 8632962 | PLKS as modifiers of the beta catenin pathway and methods of use | Helen Francis-Lang, Christopher Winter, Richard Benn Abegania Ventura, Lynn Margaret Bjerke | 2014-01-21 |
| 8481269 | PIK4CA as modifier of the Rac pathway and methods of use | Lisa Kadyk, George Ross Francis, Lynn Margaret Bjerke | 2013-07-09 |
| 8273536 | Marks as modifers of the PTEN pathway and methods of use | Michael Costa, Garth Joseph McGrath, Kim Lickteig | 2012-09-25 |
| 8105785 | Mylks as modifiers of branching morphogenesis and methods of use | Gregory D. Plowman, Felix Karim, Candace Swimmer, Hinrich Alexander Habeck, Thomas I. Koblizek +10 more | 2012-01-31 |
| 8067181 | MELKS as modifiers of the Rac pathway and methods of use | Lisa Kadyk, George Ross Francis, Kim Lickteig | 2011-11-29 |
| 7943302 | C20ORF23 as modifier of the IGFR pathway and methods of use | Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Lynn Margaret Bjerke | 2011-05-17 |
| 7927872 | ALDOs as modifiers of the IGF pathway and methods of use | Mark E. Maxwell, Michael OLLMANN, Benjamin C. Hitz | 2011-04-19 |
| 7888048 | P4HAS as modifiers of the IGFR pathway and methods of use | Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Lynn Margaret Bjerke | 2011-02-15 |
| 7888047 | PDEs as modifiers of the IGFR pathways and methods of use | Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Lynn Margaret Bjerke | 2011-02-15 |
| 7785805 | MAN2As as modifiers of the IGFR pathway and methods of use | Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Haiguang Zhang | 2010-08-31 |